Kester Capital

Frontier Medical Group acquires Genie Care

05 September 2016

The company broadens its Pressure Area Care portfolio with acquisition of Genie Care and innovative ToTo product

Frontier Medical Group ("Frontier"), the specialist medical device manufacturer, today announces its acquisition of Genie Care in a deal that sees Frontier broaden its portfolio and continue its investment in products used in the prevention and treatment of pressure ulcers.

ToTo is a patented product that is recognised as a revolution in helping clinicians and carers in the regular turning of patients. The unique turning platform is placed under any existing mattress and designed to gently turn patients at regular intervals, supporting carers and offering a new approach to “Two Hourly” or “Night Time” turning.

The ToTo system was specifically designed to prevent pressure damage and improve patient comfort, with a proven record of success in recent years. The addition of ToTo is complementary to Frontier’s existing Repose® range of pressure area care products, and will further help clinicians and carers to reduce the prevelance of pressure injuries with clinically and cost effective products in both the acute and community settings.

According to the NHS Stop The Pressure research, 700,000 people in the UK are affected by pressure ulcers each year and between 80% to 95% of these cases are preventable using the recommended SSKIN bundle approach. Repose® and ToTo tackle two of the five SSKIN steps, as Repose® pressure area care products are therapeutic surfaces with over 19 years of clinical evidence and Toto has been proven to help with the regular turning of patients.

Simon Jackson, Managing Director at Frontier Medical Group said: “This exciting acquisition allows us to broaden our range of innovative solutions supporting clinicians around the world, helping them in their work to reduce the prevalence of pressure ulcers. Pressure injury is a major issue in the global healthcare profession, and increasing our range of products will further allow Frontier to improve the lives of individuals who are at risk in both the acute and community settings.”

Mike Wilkinson, Managing Director at Genie Care said: “This integration with Frontier Medical Group is the logical next step for Genie Care. Combining Frontier’s best-in-class pressure area care products with Genie Care’s ToTo patient turning system will provide patients with the most complete pressure area care range in the market”

For more information on this acquisition visit www.frontier-group.co.uk and for more on the Repose® range of products visit www.reposedirect.com.

Contact us:

Kester Capital:
Cameron Crockett/Jeniv Shah        +44 20 3747 5700

Frontier Medical:
Simon Jackson/Matthew Bambery  +44 1495 235 800

Media Contact:
Fereshta Amir                                +44 20 3475 7168
frontier@battenhall.net

About Kester Capital

Kester Capital is a mid-market UK private equity firm investing in businesses with an enterprise value of £10-50 million. It was established in 2007 as Greenhill Capital Partners Europe, the European private equity arm of Greenhill & Co.

About Frontier Medical Group

Frontier Medical Group, based in Blackwood, South Wales, is a market leading provider of a range of specialist medical devices to healthcare professionals and end users in both the UK and internationally. Frontier’s products contribute greatly to the safety and wellbeing of its users, specifically in Pressure Area Care, Infection Control and Harm Reduction. Its main product lines are:

  • Repose® - A range of pressure area care devices (including: mattresses, cushions, foot protectors and turning systems) used in both the treatment and prevention of pressure ulcers
  • Sharpsafe® - A range of containers for the safe disposal of clinical sharps which have evolved in line with health care and legislative infection control requirements
  • eXchange - A range of products developed to meet the growing demand for specialised equipment and paraphernalia for the needle exchange and harm reduction programmes operated by healthcare providers